Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Goldsmith

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Brain, Behavior, and Immunity|December 23, 2023
Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: Meta-analyses and systematic reviewJerome Henry Taylor, Julieta Bermudez-Gomez, Marina Zhou, et al.
Molecular Psychiatry|June 14, 2018
What does plasma CRP tell us about peripheral and central inflammation in depression?Jennifer C Felger, Ebrahim Haroon, Trusharth A Patel, et al.
NPJ Schizophrenia|April 3, 2020
Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controlsDavid R Goldsmith, Nicholas Massa, Bradley D Pearce, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
Integrating Diversity, Equity, and Inclusion Into an Academic Department of Psychiatry and Behavioral SciencesNadine J Kaslow, Ann C Schwartz, Dinah K Ayna, et al.
Frontiers in Psychiatry|December 17, 2020
<i>Toxoplasma gondii</i> Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control SubjectsBradley D Pearce, Nicholas Massa, David R Goldsmith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2025
Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophreniaDavid R Goldsmith, Courtney S Ning, Gregory P Strauss, et al.
Brain, Behavior, and Immunity|November 30, 2018
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosisDavid R Goldsmith, Ebrahim Haroon, Andrew H Miller, et al.
Brain, Behavior, and Immunity|December 18, 2024
Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammationMandakh Bekhbat, Zhihao Li, Boadie W Dunlop, et al.
Brain, Behavior, and Immunity|June 28, 2026
Monocyte abundance and glycolytic reprogramming associate with motivational impairment in depressionMandakh Bekhbat, Genevieve Craig, Evanthia C Wommack, et al.
Brain, Behavior, and Immunity|July 29, 2025
The moderating role of lifetime social engagement on the relationship between C-reactive protein and negative symptoms among young adults at clinical high risk for psychosisDavid R Goldsmith, Qingyue E Yuan, Jean Addington, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Brain, Behavior, and Immunity|December 23, 2023
Immune and oxidative stress biomarkers in pediatric psychosis and psychosis-risk: Meta-analyses and systematic reviewJerome Henry Taylor, Julieta Bermudez-Gomez, Marina Zhou, et al.
Molecular Psychiatry|June 14, 2018
What does plasma CRP tell us about peripheral and central inflammation in depression?Jennifer C Felger, Ebrahim Haroon, Trusharth A Patel, et al.
NPJ Schizophrenia|April 3, 2020
Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controlsDavid R Goldsmith, Nicholas Massa, Bradley D Pearce, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
Integrating Diversity, Equity, and Inclusion Into an Academic Department of Psychiatry and Behavioral SciencesNadine J Kaslow, Ann C Schwartz, Dinah K Ayna, et al.
Frontiers in Psychiatry|December 17, 2020
<i>Toxoplasma gondii</i> Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control SubjectsBradley D Pearce, Nicholas Massa, David R Goldsmith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 24, 2025
Inflammation is associated with avolition and reduced resting state functional connectivity in corticostriatal reward circuitry in patients with schizophreniaDavid R Goldsmith, Courtney S Ning, Gregory P Strauss, et al.
Brain, Behavior, and Immunity|November 30, 2018
Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosisDavid R Goldsmith, Ebrahim Haroon, Andrew H Miller, et al.
Brain, Behavior, and Immunity|December 18, 2024
Sustained effects of repeated levodopa (L-DOPA) administration on reward circuitry, effort-based motivation, and anhedonia in depressed patients with higher inflammationMandakh Bekhbat, Zhihao Li, Boadie W Dunlop, et al.
Brain, Behavior, and Immunity|June 28, 2026
Monocyte abundance and glycolytic reprogramming associate with motivational impairment in depressionMandakh Bekhbat, Genevieve Craig, Evanthia C Wommack, et al.
Brain, Behavior, and Immunity|July 29, 2025
The moderating role of lifetime social engagement on the relationship between C-reactive protein and negative symptoms among young adults at clinical high risk for psychosisDavid R Goldsmith, Qingyue E Yuan, Jean Addington, et al.
Pageof 8